This review paper highlights and updates the role of plant based inhibitors in controlling the
triple-negative breast cancer (TNBC) via blocking the TNBC signalling pathways. Breast …

Breast cancer (BC) is sub-categorized into several well-recognized subtypes including
estrogen receptor (ER), progesterone receptor (PR), and HER2 triple-negative breast cancer …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer,
having a poor prognosis and rapid metastases. TNBC is characterized by the absence of …

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks receptors for
targeted therapy. Consequently, chemotherapy is currently the mainstay of systemic …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer which
is characterized by the absence of progesterone receptor, estrogen receptor, and human …

Triple negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer accounting for 15-20% of cases and is defined by the lack of hormonal receptors viz …

Triple negative breast cancer (TNBC) is one of the most aggressive form of breast cancer. It
is characterized by the absence of estrogen, progesterone and human epidermal growth …

Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer that
lacks estrogen, progesterone, and HER2 receptor expression. TNBC is thought to be …

Breast cancer is the most prevalent cancer in women globally and a major global health
concern. One in every twelve women worldwide will be diagnosed with this malignancy at …

Triple negative breast cancer represents multiple genomic and transcriptomic
heterogeneities. Genetic and epigenetic changes emerging in TNBC help it in acquiring …